BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qingwei Z, Dongsheng H, Duo L, Youlei W, Songxia Y, Ziqi Y, Lanjuan L. Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients. Front Oncol 2020;10:1542. [PMID: 32984012 DOI: 10.3389/fonc.2020.01542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi H, Chen Y, Huang C, Li C, Su W, Chang T, Chen P, Yin T, Tsai H, Wang J. Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study. Front Oncol 2022;12:756078. [DOI: 10.3389/fonc.2022.756078] [Reference Citation Analysis]